Literature DB >> 21365187

VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications.

Jincai Luo1, Yan Xiong, Xiaofan Han, Yao Lu.   

Abstract

Vascular endothelial growth factor (VEGF) is best known as an angiogenic factor essential for embryonic vasculogenesis and postnatal angiogenesis. Considerable evidence has accumulated that VEGF also has non-angiogenic functions. Early studies demonstrated that VEGF transcripts are ubiquitously expressed, and the phosphorylation of VEGF receptor is detectable in adult organs that have no feature of angiogenesis. Recent clinical studies showed that the inhibition of VEGF signaling results in diverse angiogenesis-irrelevant side effects involving the dysfunctions of many organs, suggesting non-angiogenic roles of VEGF in the regulation of organ homeostasis. On the other hand, VEGF stimulates endothelial cells (ECs) to express intercellular adhesion molecules that mediate physical interactions with adjacent tissue cells, or secreted various multifunctional substances that affect the functions of surrounding organs. Furthermore, very recent studies including ours have revealed VEGF as a potent agonist for endothelial exocytosis of Weibel-Palade bodies in which thrombogenic and inflammatory factors are stored. In this brief review, we highlight the importance of VEGF non-angiogenic functions in the modulation of tissue repair and organ regeneration, vascular homeostasis, and inflammation, and propose that the non-angiogenic functions are primarily mediated through the substances released from ECs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365187     DOI: 10.1007/s00109-011-0739-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  135 in total

1.  VEGF effect on vascular permeability is mediated by synthesis of platelet-activating factor.

Authors:  M G Sirois; E R Edelman
Journal:  Am J Physiol       Date:  1997-06

2.  Heterogeneity in endothelial cells from large vessels and microvessels.

Authors:  S Kumar; D C West; A Ager
Journal:  Differentiation       Date:  1987       Impact factor: 3.880

3.  Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants.

Authors:  H Gille; J Kowalski; B Li; J LeCouter; B Moffat; T F Zioncheck; N Pelletier; N Ferrara
Journal:  J Biol Chem       Date:  2000-10-31       Impact factor: 5.157

4.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

Review 5.  Role of platelet-activating factor in cardiovascular pathophysiology.

Authors:  G Montrucchio; G Alloatti; G Camussi
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

6.  Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.

Authors:  Sandrine Faivre; Catherine Delbaldo; Karina Vera; Caroline Robert; Stéphanie Lozahic; Nathalie Lassau; Carlo Bello; Samuel Deprimo; Nicoletta Brega; Giorgio Massimini; Jean-Pierre Armand; Paul Scigalla; Eric Raymond
Journal:  J Clin Oncol       Date:  2005-11-28       Impact factor: 44.544

Review 7.  The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.

Authors:  Hiroyuki Takahashi; Masabumi Shibuya
Journal:  Clin Sci (Lond)       Date:  2005-09       Impact factor: 6.124

Review 8.  Life history of eNOS: partners and pathways.

Authors:  David M Dudzinski; Thomas Michel
Journal:  Cardiovasc Res       Date:  2007-04-03       Impact factor: 10.787

9.  Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain.

Authors:  Abner Louissaint; Sudha Rao; Caroline Leventhal; Steven A Goldman
Journal:  Neuron       Date:  2002-06-13       Impact factor: 17.173

10.  Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis.

Authors:  J D Pearlman; M G Hibberd; M L Chuang; K Harada; J J Lopez; S R Gladstone; M Friedman; F W Sellke; M Simons
Journal:  Nat Med       Date:  1995-10       Impact factor: 53.440

View more
  9 in total

1.  Autologous microfragmented adipose tissue reduces inflammatory and catabolic markers in supraspinatus tendon cells derived from patients affected by rotator cuff tears.

Authors:  Pietro Randelli; Laura de Girolamo; Marco Viganò; Gaia Lugano; Carlotta Perucca Orfei; Alessandra Menon; Enrico Ragni; Alessandra Colombini; Paola De Luca
Journal:  Int Orthop       Date:  2020-07-08       Impact factor: 3.075

2.  Insights into the dual role of angiogenesis following stroke.

Authors:  Ruslan Rust
Journal:  J Cereb Blood Flow Metab       Date:  2020-02-16       Impact factor: 6.200

3.  Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery.

Authors:  Qizhi Wang; Xiangguo Tian; Chunqing Zhang; Qiangxiu Wang
Journal:  Med Oncol       Date:  2011-11-19       Impact factor: 3.064

4.  Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestation.

Authors:  Alan Leviton; Elizabeth N Allred; Hidemi Yamamoto; Raina N Fichorova
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

5.  Myosin VI and cardiomyopathy: Left ventricular hypertrophy, fibrosis, and both cardiac and pulmonary vascular endothelial cell defects in the Snell's waltzer mouse.

Authors:  Peter S Hegan; Anthony A Lanahan; Michael Simons; Mark S Mooseker
Journal:  Cytoskeleton (Hoboken)       Date:  2015-08

6.  Signaling required for blood vessel maintenance: molecular basis and pathological manifestations.

Authors:  Masahiro Murakami
Journal:  Int J Vasc Med       Date:  2011-12-06

Review 7.  Anti-angiogenic alternatives to VEGF blockade.

Authors:  Kabir A Khan; Roy Bicknell
Journal:  Clin Exp Metastasis       Date:  2015-11-30       Impact factor: 5.150

Review 8.  The role IL-1 in tumor-mediated angiogenesis.

Authors:  Elena Voronov; Yaron Carmi; Ron N Apte
Journal:  Front Physiol       Date:  2014-03-28       Impact factor: 4.566

9.  Autologous Microfragmented Adipose Tissue Reduces the Catabolic and Fibrosis Response in an In Vitro Model of Tendon Cell Inflammation.

Authors:  Marco Viganò; Gaia Lugano; Carlotta Perucca Orfei; Alessandra Menon; Enrico Ragni; Alessandra Colombini; Paola De Luca; Pietro Randelli; Laura de Girolamo
Journal:  Stem Cells Int       Date:  2019-12-05       Impact factor: 5.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.